Safe to use in almost any inner organ
If the Gold Anchor marker is transferred over to longer EUS-FNA or EBUS-TBNA needles, Gold Anchor can also be placed in:
- Pancreatic and
- Central lung tumors.
Fiducial markers are often used to guide external beam radiotherapy for prostate to provide target coverage while protecting nearby sensitive organs. Gold Anchor’s industry leading thin needles and unique marker design makes it possible to proceed with CT/MR for dose planning on the same day as implantation.
Lung tumors can often be visualized with cone-beam CT but there are cases that can benefit from using fiducial markers, e.g. when there is atelectasis or when the tumor edges as blurry. Gold Anchor’s industry leading thin needles drastically reduce the risk of transthoracic implantation. And the marker can also be placed endoscopically.
Gold Anchor is suitable for percutaneous implantation in most soft tissue organs, e.g. liver, pancreas, kidney, adrenal gland, breast, oligomets in abdomen and inguinal metastases. Gold Anchor is available in the same type of ultrathin needles that has been used for over 60 years for fine needle aspiration cytology (FNAC) with no to very little harm.
Breast cancer is the most common cancer diagnosed in women worldwide. Radiotherapy boost treatment are becoming more and more common as well as the delineation of the target area on MRI. Gold Anchor markers provide strong tissue attachment in the tumor bed and provide good visibility both on kV and MR images.
The cervix is prone to movement. Fiducial markers are therefore useful to guide both external-beam and internal radiotherapy (brachy). However, traditional markers have a tendency to migrate and fall out of the vaginal wall and cervix while Gold Anchors expand outside the needle and anchor in the tissue.